Coinbase Lists Two Altcoins on its Upcoming Projects Lineup, Fueling Cryptocurrency Surge
In the world of cryptocurrency, two significant additions have been made to Coinbase's listing roadmap: Bio Protocol (BIO) and Euler (EUL). As of July 31, 2025, Bio Protocol (BIO) has officially been listed and is now available for trading on the top US crypto exchange, subject to meeting liquidity conditions.
Bio Protocol (BIO) Makes its Debut on Coinbase
Bio Protocol (BIO) is a biotechnology-related project that aims to "accelerate biotechnology by giving global communities of patients, scientists, and biotech professionals the ability to collectively fund, build, and own tokenized biotech projects and intellectual property." Supported on the Ethereum network as an ERC-20 token, BIO was added to Coinbase's listing roadmap on July 29, 2025.
Following its addition to the roadmap, BIO experienced a short-term price rally of about 17%, reflecting the typical "Coinbase effect" volatility. However, its long-term impact may be limited due to BIO already being traded on major exchanges like Binance and Kraken. As of July 31, BIO had a market cap around $131 million and was actively traded on Coinbase in supported regions.
Euler (EUL) Awaits Official Listing on Coinbase
Euler (EUL), another decentralized finance (DeFi) lending platform, was also added to Coinbase's asset roadmap alongside BIO on July 29, 2025. Although it has not yet been confirmed as officially listed, its addition to the roadmap indicates potential future listing. After the announcement, EUL's price surged briefly from about $12.63 to $14.12 before stabilizing near the $13 range.
Similar to BIO, EUL is already traded on several established platforms, which may moderate the impact of a potential Coinbase listing.
Stay Updated with The Daily Hodl
For the latest news, updates, and insights on Bitcoin, Ethereum, Altcoins, Financeflux, Trading, NFTs, Blockchain, Futuremash, Regulators, Scams, Hacks & Breaches, and Industry Announcements, join us on Telegram, X, and Facebook. You can also find us under HODLX for Latest Stories, FAQ, and Submit Guest Post.
[1] Bio Protocol (BIO) officially listed on Coinbase Exchange on July 31, 2025, with trading beginning if liquidity conditions were met. It is supported on the Ethereum network as an ERC-20 token. [2] Following its addition to Coinbase's listing roadmap on July 29, BIO experienced a short-term price rally of about 17%, reflecting typical "Coinbase effect" volatility. [3] As of July 31, BIO had a market cap around $131 million and was actively traded on Coinbase in supported regions. [4] Euler (EUL), also added to Coinbase’s asset roadmap alongside BIO on July 29, 2025, has not yet been confirmed as officially listed, but its addition indicated potential future listing. [5] After the announcement, EUL’s price surged briefly from about $12.63 to $14.12 before stabilizing near the $13 range. [6] Similar to BIO, EUL is already traded on several established platforms, which may moderate the impact of a potential Coinbase listing.
INDUSTRY ANNOUNCEMENTS: Latest, Press Releases, Chainwire, Sponsored Posts, Submit Your Content
Covering the future of finance, including macro, bitcoin, ethereum, crypto, and web 3.
- The Biotechnology-oriented project, Bio Protocol (BIO), uses blockchain technology to enable the funding, building, and ownership of tokenized biotech projects, showcasing the potential of decentralized finance (DeFi) in expanding to various sectors.
- Coinbase's addition of Euler (EUL), a DeFi lending platform, to its asset roadmap indicates the exchange's commitment to embracing diverse cryptocurrency projects, paving the way for a decentralized future in finance.
